STOCK TITAN

Theratechnologies Reports on its Annual Meeting of Shareholders

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Theratechnologies Inc. held its annual meeting of shareholders, where candidates for the Board of Directors were elected and KPMG LLP was appointed as auditors. The voting results showed high support for all candidates, with Frank Holler becoming the new Chair of the Board.

Positive
  • None.
Negative
  • None.

MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.

Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion:

 FOR
% FORABSTENTION
% ABSTENTION
Joseph Arena22,405,047 93.09%1,663,754 6.91%
Frank Holler21,008,601 87.29%3,060,200 12.71%
Paul Lévesque20,966,427 87.11%3,102,374 12.89%
Andrew Molson21,067,050 87.53%3,001,751 12.47%
Dawn Svoronos20,964,213 87.10%3,104,588 2.90%
Elina Tea21,734,254 90.30%2,334,547 9.70%
Dale Weil21,009,681 87.29%3,059,120 12.71%
Jordan Zwick23,107,383 96.01%961,418 3.99%

Frank Holler will now act as Chair of the Board of Directors of the Company.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800


FAQ

Who were elected to Theratechnologies' Board of Directors at the annual meeting of shareholders?

Joseph Arena, Frank Holler, Paul Lévesque, Andrew Molson, Dawn Svoronos, Elina Tea, Dale Weil, and Jordan Zwick were elected.

Who was appointed as the auditors for Theratechnologies for the current fiscal year?

KPMG LLP was appointed as the auditors for the current fiscal year.

Who is the new Chair of the Board of Directors of Theratechnologies?

Frank Holler is the new Chair of the Board of Directors.

Theratechnologies Inc.

NASDAQ:THTX

THTX Rankings

THTX Latest News

THTX Stock Data

60.69M
34.20M
6.29%
50.89%
0.03%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
Montreal

About THTX

theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.